Cargando…

Corrigendum: Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan

Detalles Bibliográficos
Autores principales:	Umakhanova, Zoya R., Bardakov, Sergey N., Mavlikeev, Mikhail O., Chernova, Olga N., Magomedova, Raisat M., Akhmedova, Patimat G., Yakovlev, Ivan A., Dalgatov, Gimat D., Fedotov, Valerii P., Isaev, Artur A., Deev, Roman V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394749/ https://www.ncbi.nlm.nih.gov/pubmed/28428771 http://dx.doi.org/10.3389/fneur.2017.00145

Ejemplares similares

Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan
por: Umakhanova, Zoya R., et al.
Publicado: (2017)

Glu20Ter Variant in PLEC 1f Isoform Causes Limb-Girdle Muscle Dystrophy with Lung Injury
por: Deev, Roman V., et al.
Publicado: (2017)

Magnetic resonance imaging pattern variability in dysferlinopathy
por: Bardakov, Sergey N., et al.
Publicado: (2021)

Intrafamilial Phenotypic Variability of Collagen VI-Related Myopathy Due to a New Mutation in the COL6A1 Gene
por: Bardakov, Sergey N., et al.
Publicado: (2021)

Genetic screening of an endemic mutation in the DYSF gene in an isolated, mountainous population in the Republic of Dagestan
por: Bardakov, Sergey N., et al.
Publicado: (2023)

Serum Cytokine Profile in a Patient Diagnosed with Dysferlinopathy
por: Khaiboullina, Svetlana F., et al.
Publicado: (2017)

The neurological presentations associated with COVID-19: A retrospective single-center clinical study in the Republic of Dagestan, Russia
por: Gadzhieva, Zukhra, et al.
Publicado: (2021)

Predictors of severe outcome of COVID-19: A retrospective single-center clinical study in the Republic of Dagestan, Russia
por: Gadzhieva, Zukhra, et al.
Publicado: (2021)

Powdery mildew resistance of barley accessions from Dagestan
por: Abdullaev, R.A., et al.
Publicado: (2021)

Therapeutic exon skipping for dysferlinopathies?
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2010)

Dysferlin and Animal Models for Dysferlinopathy
por: Kobayashi, Kinji, et al.
Publicado: (2012)

Heterogeneous Characteristics of Korean Patients with Dysferlinopathy
por: Park, Hyung Jun, et al.
Publicado: (2012)

Portrait of Dysferlinopathy: Diagnosis and Development of Therapy
por: Bouchard, Camille, et al.
Publicado: (2023)

Metagenomic Analysis of Ampelographic Collections of Dagestan Revealed the Presence of Two Novel Grapevine Viruses
por: Shvets, Darya, et al.
Publicado: (2022)

Dual Adeno-Associated Virus 9 with Codon-Optimized DYSF Gene Promotes In Vivo Muscle Regeneration and May Decrease Inflammatory Response in Limb Girdle Muscular Dystrophy Type R2
por: Yakovlev, Ivan A., et al.
Publicado: (2023)

Muscle membrane repair and inflammatory attack in dysferlinopathy
por: Han, Renzhi
Publicado: (2011)

Differential Immunohistological Features of Inflammatory Myopathies and Dysferlinopathy
por: Choi, Jae-Hwan, et al.
Publicado: (2009)

Dysferlinopathy Fibroblasts Are Defective in Plasma Membrane Repair
por: Matsuda, Chie, et al.
Publicado: (2015)

A novel mutation in the PEX26 gene in a family from Dagestan with members affected by Zellweger spectrum disorder
por: Semenova, Natalia A., et al.
Publicado: (2021)

Results of an International Postmarketing Surveillance Study of pl-VEGF165 Safety and Efficacy in 210 Patients with Peripheral Arterial Disease
por: Deev, Roman, et al.
Publicado: (2017)

Dysferlinopathy course and sportive activity: clues for possible treatment
por: Angelini, C., et al.
Publicado: (2011)

Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects
por: Petersen, Jens A., et al.
Publicado: (2015)

The Clinical Outcome Study for dysferlinopathy: An international multicenter study
por: Harris, Elizabeth, et al.
Publicado: (2016)

AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy
por: Ono, Hiroya, et al.
Publicado: (2020)

AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models
por: Sondergaard, Patricia C, et al.
Publicado: (2015)

Diagnosis by protein analysis of dysferlinopathy in two patients mistaken as polymyositis
por: Angelini, Corrado, et al.
Publicado: (2011)

Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy
por: Lee, Yun-Sil, et al.
Publicado: (2015)

Water T2 could predict functional decline in patients with dysferlinopathy
por: Moore, Ursula, et al.
Publicado: (2022)

Twenty-one lectures on complex analysis: a first course
por: Isaev, Alexander
Publicado: (2017)

Eight Whole-Genome Assemblies of Yersinia pestis subsp. microtus bv. caucasica Isolated from the Common Vole (Microtus arvalis) Plague Focus in Dagestan, Russia
por: Kislichkina, Angelina A., et al.
Publicado: (2017)

Genetic profile for suspected dysferlinopathy identified by targeted next-generation sequencing
por: Izumi, Rumiko, et al.
Publicado: (2015)

Assessment of disease progression in dysferlinopathy: A 1-year cohort study
por: Moore, Ursula, et al.
Publicado: (2019)

Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials
por: Diaz-Manera, Jordi, et al.
Publicado: (2018)

Clinical, Neurophysiological, Radiological, Pathological, and Genetic Features of Dysferlinopathy in Saudi Arabia
por: Alharbi, Norah, et al.
Publicado: (2022)

Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and in vivo validation
por: Xie, Yan, et al.
Publicado: (2022)

Cardiac and pulmonary findings in dysferlinopathy: A 3‐year, longitudinal study
por: Moore, Ursula, et al.
Publicado: (2022)

Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial
por: Walter, Maggie C, et al.
Publicado: (2013)

Genome-wide expression analysis comparing hypertrophic changes in normal and dysferlinopathy mice
por: Lee, Yun-Sil, et al.
Publicado: (2015)

Dysferlin Gene Mutation Spectrum in a Large Cohort of Chinese Patients with Dysferlinopathy
por: Jin, Su-Qin, et al.
Publicado: (2016)

Serum exosomes can restore cellular function in vitro and be used for diagnosis in dysferlinopathy
por: Dong, Xue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_flb3lnf76qnpl7elk61ma6aju6